Back to search
FDAFDA · Food and drugs·Recall number D-0109-2025

Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-460-30

Published December 11, 2024 · Recall initiated: November 27, 2024

Summary

FDA records drug Class II recall D-0109-2025, published December 11, 2024 and initiated November 27, 2024. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 2,396 bottles; Lot: Lot # 44550, Exp 12/31/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AvKARE
Distributor
USA Nationwide
Lot
Lot # 44550, Exp 12/31/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-460-30 recalled?

Yes. FDA published recall D-0109-2025 on December 11, 2024. Reported hazard: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.

What should I do if I have this product?

Voluntary: Firm initiated · Letter